ERBB2 and lung carcinoma: Between July 2013 and June 2017, 206 patients with pathologically confirmed lung cancer were screened with a next-generation sequencing (NGS) panel including HER2 and EGFR genes at Kindai University Hospital (Supplementary Figure 1).